Zephyr Valve Registry (ZEVR) for the Treatment of Emphysema

Submitted by centretek on Sat, 10/15/2022 - 10:29
Source URL
https://www.inova.org/clinical-trials/zephyr-valve-registry-zevr-emphysema-treatment
Description
General Information Age Group Adults Status Recruiting Protocol Number NCT04186546 Background Information This research study is studying the Zephyr Valve procedure for the treatment of emphysema. Pulmonx Corporation, the manufacturer of the Zephyr Valve is sponsoring this research study. Pulmonx, the manufacturer of the Zephyr Valve, is continuing to collect data on the safety and efficacy of this treatment in a Registry. Participants will allow the Sponsor (Pulmonx) to collect relevant medical information for this Registry. Offered At Inova Schar Cancer Institute 8081 Innovation Park Dr. Fairfax, VA 22031A department of Inova Fairfax Hospital Inova Fairfax Hospital 3300 Gallows Rd. Falls Church, VA 22042 Eligibility Information Adults 18 years of age or older Subjects with severe emphysema considered eligible for the procedure by their doctor Subjects able to consent to the collection of their health information • Additional eligibility in protocol Ineligibility Information Subjects determined to have collateral ventilation between the target(s) and ipsilateral lobe(s) Additional ineligibility in protocol For additional information, please see: https://www.clinicaltrials.gov/ct2/show/NCT04186546 Contact Information Contact Name Mahwish Bari Contact Phone 571-472-1796 Contact Email Send Email
Clinical Trials Sub categories
Cancer
Crawled Content Type
Clinical Trials
Age Group
Adults
is_synonym
Off
Also a children's page
Off